Evidence map›Paper›PMID 38961469›Full record

ArticleJournal of medical case reports2024

Unmasking an unusual presentation of Hodgkin's lymphoma masquerading as ocular inflammation: a case report.

Anna Zein-El-Din, Rami Abdo, Amina Elbachti, Gabriel Boustani, Dany Salik, Sayeh Pourjavan

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anna Zein-El-Din *Department of Ophthalmology, CHIREC Hospital Group, Delta Hospital, Brussels, Belgium. annazeineldin@gmail.com.
Rami Abdo *Department of Ophthalmology, CHIREC Hospital Group, Delta Hospital, Brussels, Belgium.
Amina ElbachtiFaculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium.
Gabriel BoustaniDepartment of Ophthalmology, CHIREC Hospital Group, Delta Hospital, Brussels, Belgium.
Dany SalikDepartment of Ophthalmology, CHIREC Hospital Group, Delta Hospital, Brussels, Belgium.
Sayeh PourjavanDepartment of Ophthalmology, CHIREC Hospital Group, Delta Hospital, Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHodgkin's lymphoma (HL) is an extremely rare cause of ocular inflammation that is usually not considered in the typical workup of uveitis and other eye diseases. A few cases of ocular inflammation were reported previously showcasing HL with absence of typical symptoms of HL at presentation. Acknowledging the potential ocular inflammation associated with HL can prompt ophthalmologists to broaden their diagnostic approach and collaborate with internal medicine departments to investigate this rare yet significant etiology. CASE PRESENTATION: A 17-year-old Caucasian woman presenting unilateral panuveitis was later diagnosed with HL. The ocular findings were non-necrotizing scleritis, anterior uveitis, vitritis, white/yellowish chorioretinal lesions, papillitis and vasculitis. A left supra-clavicular lymph node biopsy confirmed the diagnosis of nodular sclerosing Hodgkin's lymphoma stage IIB. Other causes of uveitis were excluded. Chemotherapy led to remission of the disease and the ocular lesions became quiescent with persistent pigmented chorioretinal scars.

conclusionsHodgkin's lymphoma should be considered in the differential diagnosis of diseases that can occasionally be revealed by unilateral ocular inflammation. A comprehensive, multidisciplinary approach is key to properly assessing such cases.

Indexed as

Hodgkin DiseaseAdolescentAntineoplastic Combined Chemotherapy ProtocolsDiagnosis, DifferentialFemaleHumansPanuveitisScleritisUveitisCase reportHodgkin’s lymphomaOcular inflammationUveitis

Identifiers

PMID38961469
PMCPMC11223416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.